Eosinophilic Granulomatosis With Polyangiitis Cohort

计划入组 50 人 · 首次发布于 2017 年 1 月 30 日

Ocular Manifestations of Granulomatosis With Polyangiitis.

计划入组 70 人 · 首次发布于 2026 年 6 月 24 日

Rituximab in Eosinophilic Granulomatosis With Polyangiitis

计划入组 107 人 · 首次发布于 2016 年 6 月 21 日

Mepolizumab(Nucala)

Rx

phospholipids with phosphatidylcholine

Trunc Abeta with BT

The Trustee for Weigh Less With Jess Trust

Australia

NATIONAL REHABILITATION CENTER FOR PERSONS WITH DISABILITIES HOSPITAL

Japan

Jiangsu Province Hospital (The First Affiliated Hospital With Nanjing Medical University)

China

Fasenra Approved in the EU for Eosinophilic Granulomatosis with Polyangiitis

Benralizumab Shows Superior Long-Term Outcomes in Eosinophilic Granulomatosis with Polyangiitis

Fasenra Receives FDA Approval for Eosinophilic Granulomatosis with Polyangiitis